Australasian Physical & Engineering Sciences in Medicine (2018) 41:1–2 https://doi.org/10.1007/s13246-018-0621-3 GUEST EDITORIAL 1,2 Scott Penfold Published online: 29 January 2018 © Australasian College of Physical Scientists and Engineers in Medicine 2018 In the September 2012 issue of this journal, Juergen Meyer or VMAT) with passively scattered proton therapy (PSPT). in his Guest Editorial “Proton therapy: decisions, decisions” The degree of conformity made possible with newer proton considered the broad and challenging question of whether pencil beam scanning (PBS) exceeds that of PSPT systems proton therapy could be considered a wise investment for in many cases and as such comparisons of IMRT/VMAT and cancer treatment . Discussions concerning this topic usu- PSPT may be unrelated to a comparison of IMRT/VMAT ally centre around the large capital expenditure required and and PBS. The next major advancement may mean a similar the lack of clinical evidence in the form of phase III ran- redundancy in comparing IMRT/VMAT and PBS. So what domized clinical trials (RCTs) supporting proton therapy. are the alternatives? Some suggest that in silico clinical tri- Meyer does not pass any firm judgements concerning the als may be used to determine which technology of the day is cost-benefit of proton therapy.
Australasian Physical & Engineering Sciences in Medicine – Springer Journals
Published: Jan 29, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera